Subject(s)
Access to Information/ethics , Global Health/ethics , Information Dissemination/methods , Publishing/organization & administration , Awareness/ethics , Biodiversity , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/virology , Climate Change , Ecosystem , Emergencies/epidemiology , Global Warming/prevention & control , Humans , Journalism, Medical/standards , Prognosis , Public Health/trends , Publishing/statistics & numerical data , SARS-CoV-2/geneticsSubject(s)
COVID-19/therapy , General Practice/organization & administration , Australia/epidemiology , COVID-19/epidemiology , COVID-19/transmission , COVID-19/virology , COVID-19 Vaccines/administration & dosage , General Practice/methods , General Practitioners , Humans , Pandemics/prevention & control , Professional Role , Publishing/organization & administration , VaccinationABSTRACT
BACKGROUND AND AIMS: The spreading speed of the COVID-19 pandemic forced the medical community to produce efforts in updating and sharing the evidence about this new disease, trying to preserve the accuracy of the data but at the same time avoiding the potentially harmful delay from discovery to implementation. The aim of our analysis was to assess the impact of the COVID-19 pandemic on medical literature in terms of proportion of COVID-19-related published papers and temporal patterns of publications within a sample of general/internal medicine and cardiology journals. METHODS: We searched through PubMed scientific papers published from 1 January 2020 to 31 January 2021 about COVID-19 in ten major medical journals, of which five were in general/internal medicine and five in the cardiology field. We analyzed the proportion of COVID-19-related papers, and we examined temporal trends in the number of published papers. RESULTS: Overall, the proportion of COVID-19-related papers was 18.5% (1986/10â756). This proportion was higher among the five selected general/internal medicine journals, compared with cardiology journals (23.8% vs 9.5%). The vast majority of papers were not original articles; in particular, in cardiology journals, there were 28% 'original articles', 17% 'review articles' and 55.1% 'miscellaneous', compared with 20.2%, 5.1% and 74.7% in general/internal medicine journals, respectively. CONCLUSIONS: Our analysis highlights the big impact of the COVID-19 pandemic on international scientific literature. General and internal medicine journals were mainly involved, with cardiology journals only at a later time.
Subject(s)
COVID-19 , Information Dissemination/methods , Publishing , COVID-19/epidemiology , COVID-19/prevention & control , Cardiology/methods , Humans , Internal Medicine/methods , Periodicals as Topic , Publishing/organization & administration , Publishing/trends , SARS-CoV-2Subject(s)
COVID-19 , Communicable Disease Control , Ethnopsychology/trends , Mental Health/trends , Periodicals as Topic/trends , Publishing/organization & administration , Asia/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/psychology , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Humans , Iran , SARS-CoV-2Subject(s)
COVID-19 , Olfaction Disorders , Peer Review, Research/methods , Publishing , COVID-19/complications , COVID-19/epidemiology , Humans , Information Dissemination/methods , Internationality , Olfaction Disorders/diagnosis , Olfaction Disorders/epidemiology , Olfaction Disorders/etiology , Publishing/organization & administration , Publishing/standards , Publishing/trends , SARS-CoV-2ABSTRACT
COVID-19 first presented in Wuhan, Hubei Province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. As of 4th of May more than 3.2 million people have been infected and over 250,000 people has died. Since the very start, scientists and researchers have tried to utilize this case to publish academic experiences and suggestions toward fighting this virus, which is lethal in some cases. To date, more than 9,000 academic papers have been published since December 2019. The quality of publications varies from a plane letter to editor to randomized studies. This review aims to analyse the current published literature related to COVID-19 and assess the quality of such articles.